Enhancing Oral Vaccine Potency by Targeting Intestinal M Cells

Overview

Journal PLoS Pathog

Specialty Microbiology

Date 2010 Nov 19

PMID 21085599

Citations 63

Authors

Ali Azizi

Ashok Kumar

Francisco Diaz-Mitoma

Jiri Mestecky

Affiliations

Soon will be listed here.

Abstract

The immune system in the gastrointestinal tract plays a crucial role in the control of infection, as it constitutes the first line of defense against mucosal pathogens. The attractive features of oral immunization have led to the exploration of a variety of oral delivery systems. However, none of these oral delivery systems have been applied to existing commercial vaccines. To overcome this, a new generation of oral vaccine delivery systems that target antigens to gut-associated lymphoid tissue is required. One promising approach is to exploit the potential of microfold (M) cells by mimicking the entry of pathogens into these cells. Targeting specific receptors on the apical surface of M cells might enhance the entry of antigens, initiating the immune response and consequently leading to protection against mucosal pathogens. In this article, we briefly review the challenges associated with current oral vaccine delivery systems and discuss strategies that might potentially target mouse and human intestinal M cells.

Citing Articles

Glycosylated SARs Cov 2 interaction with plant lectins.

Devi O, Singh S, Kamei R, Sharma H, Devi M, Brahmacharimayum N Glycoconj J. 2024; 41(3):185-199.

PMID: 38748325 DOI: 10.1007/s10719-024-10154-x.

Synergistic Effect of Retinoic Acid and Lactoferrin in the Maintenance of Gut Homeostasis.

Pena-Juarez M, Guadarrama-Escobar O, Serrano-Castaneda P, Mendez-Albores A, Vazquez-Duran A, Vera-Graziano R Biomolecules. 2024; 14(1).

PMID: 38254678 PMC: 10813542. DOI: 10.3390/biom14010078.

Mannose-specific plant and microbial lectins as antiviral agents: A review.

Gupta A, Yadav K, Yadav A, Ahmad R, Srivastava A, Kumar D Glycoconj J. 2024; 41(1):1-33.

PMID: 38244136 DOI: 10.1007/s10719-023-10142-7.

Expression of FimH Enhances Trafficking of an Orally Delivered Vaccine to Immune Inductive Sites via Antigen-Presenting Cells.

Vilander A, Shelton K, LaVoy A, Dean G Vaccines (Basel). 2023; 11(7).

PMID: 37514978 PMC: 10384470. DOI: 10.3390/vaccines11071162.

Application of Nano-Delivery Systems in Lymph Nodes for Tumor Immunotherapy.

Xia Y, Fu S, Ma Q, Liu Y, Zhang N Nanomicro Lett. 2023; 15(1):145.

PMID: 37269391 PMC: 10239433. DOI: 10.1007/s40820-023-01125-2.

References

Lim J, Na H, Lee H, Choy H, Park S, Han J . Caveolae-mediated entry of Salmonella typhimurium in a human M-cell model. Biochem Biophys Res Commun. 2009; 390(4):1322-7. DOI: 10.1016/j.bbrc.2009.10.145. View

Wells J, Mercenier A . Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria. Nat Rev Microbiol. 2008; 6(5):349-62. PMC: 7096801. DOI: 10.1038/nrmicro1840. View

Pouwels P, Leer R, Shaw M, Tielen F, Smit E, Martinez B . Lactic acid bacteria as antigen delivery vehicles for oral immunization purposes. Int J Food Microbiol. 1998; 41(2):155-67. DOI: 10.1016/s0168-1605(98)00048-8. View

Beagley K, Mega J, Fujihashi K, Kiyono H, McGhee J . Induction of T helper cells and cytokines for mucosal IgA responses. Adv Exp Med Biol. 1992; 327:107-17. DOI: 10.1007/978-1-4615-3410-5_13. View

Brayden D, Jepson M, Baird A . Keynote review: intestinal Peyer's patch M cells and oral vaccine targeting. Drug Discov Today. 2005; 10(17):1145-57. DOI: 10.1016/S1359-6446(05)03536-1. View

Streatfield S . Plant-based vaccines for animal health. Rev Sci Tech. 2005; 24(1):189-99. View

Durrani Z, McInerney T, McLain L, Jones T, Bellaby T, Brennan F . Intranasal immunization with a plant virus expressing a peptide from HIV-1 gp41 stimulates better mucosal and systemic HIV-1-specific IgA and IgG than oral immunization. J Immunol Methods. 1998; 220(1-2):93-103. DOI: 10.1016/s0022-1759(98)00145-8. View

Boyer J, Robinson T, Maciag P, Peng X, Johnson R, Pavlakis G . DNA prime Listeria boost induces a cellular immune response to SIV antigens in the rhesus macaque model that is capable of limited suppression of SIV239 viral replication. Virology. 2005; 333(1):88-101. DOI: 10.1016/j.virol.2004.12.026. View

Fu J, Bian G, Zhao B, Dong Z, Sun X, Chen F . Enhancing efficacy and mucosa-tropic distribution of an oral HIV-PsV DNA vaccine in animal models. J Drug Target. 2009; 17(10):803-12. DOI: 10.3109/10611860903089768. View

10.

Haneberg B, Kendall D, Amerongen H, Apter F, Kraehenbuhl J, Neutra M . Induction of specific immunoglobulin A in the small intestine, colon-rectum, and vagina measured by a new method for collection of secretions from local mucosal surfaces. Infect Immun. 1994; 62(1):15-23. PMC: 186061. DOI: 10.1128/iai.62.1.15-23.1994. View

11.

Sirskyj D, Diaz-Mitoma F, Golshani A, Kumar A, Azizi A . Innovative bioinformatic approaches for developing peptide-based vaccines against hypervariable viruses. Immunol Cell Biol. 2010; 89(1):81-9. DOI: 10.1038/icb.2010.65. View

12.

Lewis D, Huo Z, Barnett S, Kromann I, Giemza R, Galiza E . Transient facial nerve paralysis (Bell's palsy) following intranasal delivery of a genetically detoxified mutant of Escherichia coli heat labile toxin. PLoS One. 2009; 4(9):e6999. PMC: 2737308. DOI: 10.1371/journal.pone.0006999. View

13.

Lu F, Ma Z, Rourke T, Srinivasan S, McChesney M, Miller C . Immunoglobulin concentrations and antigen-specific antibody levels in cervicovaginal lavages of rhesus macaques are influenced by the stage of the menstrual cycle. Infect Immun. 1999; 67(12):6321-8. PMC: 97036. DOI: 10.1128/IAI.67.12.6321-6328.1999. View

14.

Wira C, Rossoll R . Oestradiol regulation of antigen presentation by uterine stromal cells: role of transforming growth factor-beta production by epithelial cells in mediating antigen-presenting cell function. Immunology. 2003; 109(3):398-406. PMC: 1782972. DOI: 10.1046/j.1365-2567.2003.01670.x. View

15.

Gebert A, Fassbender S, Werner K, Weissferdt A . The development of M cells in Peyer's patches is restricted to specialized dome-associated crypts. Am J Pathol. 1999; 154(5):1573-82. PMC: 1866609. DOI: 10.1016/S0002-9440(10)65410-7. View

16.

Czerkinsky C, Holmgren J . Enteric vaccines for the developing world: a challenge for mucosal immunology. Mucosal Immunol. 2009; 2(4):284-7. DOI: 10.1038/mi.2009.22. View

17.

Chou M, Hartvigsen K, Hansen L, Fogelstrand L, Shaw P, Boullier A . Oxidation-specific epitopes are important targets of innate immunity. J Intern Med. 2008; 263(5):479-88. DOI: 10.1111/j.1365-2796.2008.01968.x. View

18.

Mann J, Shakir E, Carter K, Mullen A, Alexander J, Ferro V . Lipid vesicle size of an oral influenza vaccine delivery vehicle influences the Th1/Th2 bias in the immune response and protection against infection. Vaccine. 2009; 27(27):3643-9. DOI: 10.1016/j.vaccine.2009.03.040. View

19.

Gram L, Rist G, Lennernas H, Steffansen B . Impact of carriers in oral absorption: Permeation across Caco-2 cells for the organic anions estrone-3-sulfate and glipizide. Eur J Pharm Sci. 2009; 37(3-4):378-86. DOI: 10.1016/j.ejps.2009.03.008. View

20.

Lagranderie M, Winter N, Balazuc A, Gicquel B, Gheorghiu M . A cocktail of Mycobacterium bovis BCG recombinants expressing the SIV Nef, Env, and Gag antigens induces antibody and cytotoxic responses in mice vaccinated by different mucosal routes. AIDS Res Hum Retroviruses. 1998; 14(18):1625-33. DOI: 10.1089/aid.1998.14.1625. View